The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Prevduo
neostigmine methylsulfate and glycopyrrolate · NEOSTIGMINE METHYLSULFATE 1 mg/mL; GLYCOPYRROLATE .2 mg/mL · Injection · Intravenous · Endo USA
NDC 42023-0269-05 · 5 SYRINGE, PLASTIC in 1 CARTON / 3 mL in 1 SYRINGE, PLASTIC · NDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Estimated fill cost
WAC per package, as filed
$106.25
Reported to Texas DSHS · 2026 annual filing · Par Health USA, LLC
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- NDA216903
- TE code
- —
- Approval date
- Feb 23, 2023
- Patents / exclusivity
- 5 patents, 0 exclusivities
| Type | Number / code | Expires |
|---|---|---|
| patent | 11110054 | Oct 25, 2038 |
| patent | 11938217 | Oct 25, 2038 |
| patent | 10456354 | Oct 25, 2038 |
| patent | 12151020 | Oct 25, 2038 |
| patent | 12383491 | Oct 25, 2038 |
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of neostigmine methylsulfate and glycopyrrolate (Injection)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Endo USA | NEOSTIGMINE METHYLSULFATE 1 mg/mL; GLYCOPYRROLATE .2 mg/mL | Aug 26, 2026 | Sep 2, 2026 |
| Endo USA | NEOSTIGMINE METHYLSULFATE .2 mg/mL; GLYCOPYRROLATE 1 mg/mL | Jul 22, 2026 | Aug 19, 2026 |
| Endo USA | GLYCOPYRROLATE .2 mg/mL; NEOSTIGMINE METHYLSULFATE 1 mg/mL | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Prevduo — NDC 42023-0269-05," retrieved September 3, 2026, https://drugdashboards.com/drug/42023026905.
Free to cite with attribution — see how the data is put together.